<PubmedArticle>
<MedlineCitation IndexingMethod="Curated" Owner="NLM" Status="MEDLINE">
<PMID Version="1">26849131</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>10</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>02</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1179-1969</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>33</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2016</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Drugs &amp; aging</Title>
<ISOAbbreviation>Drugs Aging</ISOAbbreviation>
</Journal>
<ArticleTitle>Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO.</ArticleTitle>
<Pagination>
<MedlinePgn>75-85</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s40266-016-0347-4</ELocationID>
<Abstract>
<AbstractText>Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. It has also recently been shown to have protective effects against subchondral bone remodelling. Following the end of the revision procedure by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency, the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) constituted a panel of 11 experts to better define the real place of diacerein in the armamentarium for treating OA. Based on a literature review of clinical trials and meta-analyses, the ESCEO confirms that the efficacy of diacerein is similar to that of non-steroidal anti-inflammatory drugs (NSAIDs) after the first month of treatment, and superior to that of paracetamol. Additionally, diacerein has shown a prolonged effect on symptoms of several months once treatment was stopped. The use of diacerein is associated with common gastrointestinal disorders such as soft stools and diarrhoea, common mild skin reactions, and, uncommonly, hepatobiliary disorders. However, NSAIDs and paracetamol are known to cause potentially severe hepatic, gastrointestinal, renal, cutaneous and cardiovascular reactions. Therefore, the ESCEO concludes that the benefit-risk balance of diacerein remains positive in the symptomatic treatment of hip and knee osteoarthritis. Furthermore, similarly to other SYSADOAs, the ESCEO positions diacerein as a first-line pharmacological background treatment of osteoarthritis, particularly for patients in whom NSAIDs or paracetamol are contraindicated. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pavelka</LastName>
<ForeName>Karel</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Institute of Rheumatology and Clinic of Rheumatology, Charles University, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bruyère</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium. olivier.bruyere@ulg.ac.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cooper</LastName>
<ForeName>Cyrus</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>MRC Lifecourse Epidemiology Unit and NIHR Nutrition Biomedical Research Centre, University of Southampton, Southampton, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kanis</LastName>
<ForeName>John A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leeb</LastName>
<ForeName>Burkhard F</ForeName>
<Initials>BF</Initials>
<AffiliationInfo>
<Affiliation>2nd Department of Medicine, State Hospital Stockerau, Centre for Rheumatology, Lower Austria, Karl Landsteiner Institute for Clinical Rheumatology, Stockerau, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maheu</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Rheumatology Department, AP-HP, St-Antoine Hospital, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martel-Pelletier</LastName>
<ForeName>Johanne</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame-Hospital, Montreal, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Monfort</LastName>
<ForeName>Jordi</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Rheumatology Service, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pelletier</LastName>
<ForeName>Jean-Pierre</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame-Hospital, Montreal, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rizzoli</LastName>
<ForeName>René</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Bone Diseases, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reginster</LastName>
<ForeName>Jean-Yves</ForeName>
<Initials>JY</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>MC_U147585819</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>MC_U147585827</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>MC_UP_A620_1014</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>MC_UU_12011/1</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>New Zealand</Country>
<MedlineTA>Drugs Aging</MedlineTA>
<NlmUniqueID>9102074</NlmUniqueID>
<ISSNLinking>1170-229X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000880">Anthraquinones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003692">Delayed-Action Preparations</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4HU6J11EL5</RegistryNumber>
<NameOfSubstance UI="C025292">diacetylrhein</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="ErratumIn">
<RefSource>Drugs Aging. 2017 May;34(5):413</RefSource>
<PMID Version="1">28349413</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000880">Anthraquinones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000893">Anti-Inflammatory Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016723">Bone Remodeling</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003692">Delayed-Action Preparations</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010003">Osteoarthritis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060735">Pharmacovigilance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>2</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>2</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26849131</ArticleId>
<ArticleId IdType="doi">10.1007/s40266-016-0347-4</ArticleId>
<ArticleId IdType="pii">10.1007/s40266-016-0347-4</ArticleId>
<ArticleId IdType="pmc">PMC4756045</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Arzneimittelforschung. 1988 May;38(5):744-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3415721</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Phytomedicine. 2000 Jun;7(3):177-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11185727</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2000 Oct;43(10):2339-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11037895</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 1994 Apr;37(4):529-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8147930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Pharmacol. 2003 Feb 1;65(3):377-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12527330</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2011 Sep;8(9):e1001098</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21980265</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Inflammation. 2003 Aug;27(4):233-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14527176</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clinics (Sao Paulo). 2006 Oct;61(5):461-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17072445</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Osteoarthritis Cartilage. 2007 Jun;15(6):605-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17448700</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Rheumatol. 2007 Jul-Aug;25(4):546-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17888210</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drugs Aging. 1998 Sep;13(3):245-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9789728</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Rheumatol. 2009 Oct;28(10):1193-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19597913</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drugs Aging. 2015 Mar;32(3):179-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25701074</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2006;(1):CD005117</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16437519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Gastroenterol. 2008 Apr;103(4):872-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18371130</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacoeconomics. 1998 Jan;13(1 Pt 2):135-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10176148</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Pharmacol. 1992 Apr;33(4):357-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1576063</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2006 Mar 28;113(12):1578-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16534006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 1998 Apr;25(4):753-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9558181</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2005 Dec;42(6):1364-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16317692</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2003 Dec;62(12):1145-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14644851</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Res Ther. 2008;10(3):R71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18578867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2006 Jun 3;332(7553):1302-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16740558</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Prat. 1996 Mar 15;46(6 Spec No):S35-S39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8731730</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Dec 4-10;364(9450):2021-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15582059</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2008 Dec;67(12):1716-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18541604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Gastroenterol. 2010 Dec 7;16(45):5651-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21128314</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2007 Dec;56(12):4055-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18050202</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 2001 Apr;28(4):814-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11327257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Osteoarthritis Cartilage. 2010 Apr;18(4):476-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20170770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Therapie. 2001 Mar-Apr;56(2):190-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11471374</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Indian Med Assoc. 2008 Jan;106(1):54-6, 58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18705272</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Osteoarthritis Cartilage. 1999 May;7(3):272-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10329302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Osteoarthritis Cartilage. 1996 Mar;4(1):77-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8731398</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2006 Sep 25;166(17):1899-906</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17000948</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Prat. 1996 Mar 15;46(6 Spec No):S49-S52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8731732</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Osteoarthritis Cartilage. 2010 Mar;18(3):289-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19857509</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Prat. 1998 Nov 1;48(17 Suppl):S24-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9865112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ther Adv Musculoskelet Dis. 2010 Apr;2(2):95-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22870441</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Osteoarthritis Cartilage. 1999 May;7(3):255-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10329300</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2004 Dec;63(12):1611-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15331394</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1997 Apr 10;336(15):1066-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9091804</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2013 Aug 31;382(9894):769-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23726390</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Saf. 2015 Mar;38(3):245-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25652235</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 1998 Dec;25(12):2417-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9858439</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Allergy. 2011 Jul;66(7):818-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21631520</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Nephrol Renovasc Dis. 2014 Dec 12;7:457-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25540591</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2006 Nov 1;164(9):881-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17005625</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2003 Nov;62 Suppl 2:ii79-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14532156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Prat. 1998 Nov 1;48(17 Suppl):S31-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9865113</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med. 1999 May 31;106(5B):13S-24S</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10390124</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2001 Aug;44(8):1736-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11508423</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Integr Care. 2002;2:e15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16896390</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2001 Nov;44(11):2539-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11710710</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 1999 Mar;42(3):545-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10088778</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Rev. 2001 Sep;53(3):357-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11546834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Rheumatol. 2014 Jul;10(7):437-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24662640</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2014;(2):CD005117</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24515444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Toxicol. 2002 Jul;91(1):22-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12193257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Arthritis Rheum. 2014 Dec;44(3):253-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24953861</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Osteoarthritis Cartilage. 2000 May;8(3):186-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10806046</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2016 Mar;75(3):552-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25732175</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Osteoarthritis Cartilage. 1997 Nov;5(6):438-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9536292</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Orthop Res. 2006 Jun;24(6):1240-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16705708</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2000 Mar 27;160(6):777-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10737277</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Saf. 2013 Feb;36(2):135-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23325533</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Rheum Dis. 2012 Feb;15(1):69-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22324949</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Indian J Dermatol. 2011 Jan;56(1):25-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21572786</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 1997 Feb;40(2):201-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9041931</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>